Temasek Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,793,376
| Closed | -$34.2M | – | 61 |
|
|
2020
Q1 | $34.2M | Hold |
4,793,376
| – | – | 0.25% | 38 |
|
|
2019
Q4 | $114M | Sell |
4,793,376
-380,792
| -7% | -$9.09M | 0.75% | 25 |
|
|
2019
Q3 | $139M | Hold |
5,174,168
| – | – | 1.02% | 19 |
|
|
2019
Q2 | $140M | Hold |
5,174,168
| – | – | 1% | 21 |
|
|
2019
Q1 | $180M | Hold |
5,174,168
| – | – | 1.24% | 20 |
|
|
2018
Q4 | $101M | Hold |
5,174,168
| – | – | 0.7% | 25 |
|
|
2018
Q3 | $138M | Hold |
5,174,168
| – | – | 0.8% | 27 |
|
|
2018
Q2 | $195M | Buy |
5,174,168
+290,600
| +6% | +$11M | 1.03% | 22 |
|
|
2018
Q1 | $159M | Hold |
4,883,568
| – | – | 0.87% | 25 |
|
|
2017
Q4 | $238M | Hold |
4,883,568
| – | – | 1.46% | 15 |
|
|
2017
Q3 | $264M | Hold |
4,883,568
| – | – | 1.54% | 13 |
|
|
2017
Q2 | $274M | Sell |
4,883,568
-1,700,000
| -26% | -$95.5M | 1.77% | 10 |
|
|
2017
Q1 | $258M | Hold |
6,583,568
| – | – | 1.92% | 8 |
|
|
2016
Q4 | $148M | Hold |
6,583,568
| – | – | 1.18% | 16 |
|
|
2016
Q3 | $150M | Hold |
6,583,568
| – | – | 1.21% | 14 |
|
|
2016
Q2 | $155M | Hold |
6,583,568
| – | – | 1.21% | 13 |
|
|
2016
Q1 | $134M | Hold |
6,583,568
| – | – | 1.06% | 16 |
|
|
2015
Q4 | $339M | Buy |
6,583,568
+750,000
| +13% | +$38.6M | 2.57% | 9 |
|
|
2015
Q3 | $249M | Hold |
5,833,568
| – | – | 2.36% | 11 |
|
|
2015
Q2 | $266M | Hold |
5,833,568
| – | – | 1.66% | 14 |
|
|
2015
Q1 | $221M | Hold |
5,833,568
| – | – | 1.66% | 11 |
|
|
2014
Q4 | $165M | Buy |
5,833,568
+1,600,000
| +38% | +$45.3M | 1.72% | 13 |
|
|
2014
Q3 | $107M | Hold |
4,233,568
| – | – | 1.14% | 14 |
|
|
2014
Q2 | $124M | Hold |
4,233,568
| – | – | 1.85% | 10 |
|
|
2014
Q1 | $110M | Hold |
4,233,568
| – | – | 1.7% | 9 |
|
|
2013
Q4 | $109M | Hold |
4,233,568
| – | – | 2.26% | 8 |
|
|
2013
Q3 | $113M | Hold |
4,233,568
| – | – | 3.13% | 6 |
|
|
2013
Q2 | $104M | Buy |
+4,233,568
| New | +$104M | 2.64% | 9 |
|